{
    "Trade/Device Name(s)": [
        "ARKTM Zonisamide Assay",
        "ARKTM Zonisamide Calibrator",
        "ARKTM Zonisamide Control"
    ],
    "Submitter Information": "ARK Diagnostics, Inc.",
    "510(k) Number": "K091884",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051211"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NWM",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "November 11, 2009",
    "Summary Letter Received Date": "November 12, 2009",
    "Submission Date": "November 24, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.3350",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Zonisamide"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer",
        "Hitachi 917"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Homogeneous immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARK Zonisamide Assay system, including calibrators and controls, for quantitative determination of zonisamide in human serum or plasma on automated clinical chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of zonisamide in human serum or plasma on automated clinical chemistry analyzers; concentrations used as an aid in management of patients treated with zonisamide",
    "fda_folder": "Toxicology"
}